Skip to main content
Clinical Trials/KCT0001713
KCT0001713
Completed
未知

Development of technology for robust production of latent virus specific cytotoxic T lymphocytes

The Catholic University of Korea, Seoul St. Mary's Hospital0 sites5 target enrollmentTBD
ConditionsNot Applicable

Overview

Phase
未知
Intervention
Not specified
Conditions
Not Applicable
Sponsor
The Catholic University of Korea, Seoul St. Mary's Hospital
Enrollment
5
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Observational Study
Sex
All

Investigators

Sponsor
The Catholic University of Korea, Seoul St. Mary's Hospital

Eligibility Criteria

Inclusion Criteria

  • Inclusion criteria include:
  • 1\. Signed informed consent form approved by the KCMC IRB.
  • 2\. Age 20 to 75 years,

Exclusion Criteria

  • 1\. Unable to provide informed consent
  • 2\. Ages under 20 or over 75
  • 3\. HIV positive individuals or either HBV or HCV positive individuals
  • 4\. Individuals with systemic or active infections requiring medical attention
  • 5\. Individuals who had previously participated in a blood donation of 200mL to 400mL within the past three months

Outcomes

Primary Outcomes

Not specified

Similar Trials